Compare Thailand and Germany using the exact treatment and its authorisation, rather than assuming all care in either country follows one pathway. The clinical evidence must match the product and diagnosis wherever it is delivered.
On this page
Regulatory questions for Germany
EMA describes the EU framework for advanced therapy medicines and warns about unregulated products. It advises patients to verify approval with the relevant authority. If a German provider cites a national pathway rather than an EU marketing authorisation, ask for the specific legal basis and its limits. EMA: advanced therapy medicines and unregulated treatments.
Check what a national pathway permits
Ask whether the proposal involves an authorised product, an approved trial or another stated legal route. A provider should identify which authority oversees it and how the documents apply to your case. Do not assume an exception or special-access description has the same meaning as general marketing authorisation.
- Is the cited permission EU-wide or specific to a national pathway?
- Which product and indication does it cover?
- What evidence, manufacturing controls and follow-up apply?
Compare the Thai proposal using the same standard
Request the exact product, diagnosis, responsible clinician and applicable Thai authorisation or research pathway. Do not transfer a foreign permission to treatment in Thailand. Read the Thai legal-status checklist and obtain the documents for the proposed date and place of care.
Compare complete costs and travel
For a Germany visit, clarify the language of clinical records, consent and discharge documents. Ask which appointments require attendance and who coordinates care once you leave. Compare a full care schedule with the Thai proposal, not only the advertised procedure fee.
Ask for an itemised estimate in euros and an equivalent Thai estimate in baht. Record the date and exchange rate if converting totals, plus payment fees. No verified matching price dataset is available here, so this guide does not claim that either country is cheaper.
Compare cancellation terms, excluded care and the cost of additional visits. Use cost planning and insurance questions.
Make the final decision around the care plan
Give both plans to a clinician familiar with your diagnosis. Ask which evidence applies, what uncertainties remain and whether travelling adds value over care available locally. Establish who will review outcomes and manage problems after the trip.
Which country has the better success rate?
No comparable audited country-wide dataset is presented here. Outcomes need to be matched by product, condition and follow-up.
Does this comparison confirm I can receive treatment?
No. Availability, eligibility and authorisation require direct confirmation for the exact intervention.
Ask about an assessment
For questions about the review process, availability or a written estimate, message Thailand Stem Cell Clinic. Ask how to share records securely. An enquiry does not confirm eligibility or that a particular treatment is offered.
All comparisons · Treatment guides · Contact information
Sources and further reading
General information, not an individual medical recommendation. Prices, coverage, eligibility and authorisation require case-specific confirmation. Source links describe their own research and jurisdictions.